Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrial fibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Innovation Arrhythmia 64

DAIC

MARCH 12, 2025

tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.

Ablation 52

Ablation Innovation Quality of Life Atrial Fibrillation 52

DAIC

DECEMBER 27, 2023

With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We In 2006, Lewis realized something was not right with his heart during one of his regular outdoor runs.

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

DAIC

MAY 21, 2024

Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

Journal of Cardiovascular Electrophysiology

OCTOBER 3, 2024

Infusion and uptake of calcium chloride during pulsed field ablation leads to greater irreversible electroporation and larger myocardial ablation lesions. Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative therapy for cardiac arrhythmias.

Ablation 45

Ablation Innovation Arrhythmia Research 45

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

Journal of Cardiovascular Electrophysiology

JANUARY 24, 2025

ABSTRACT Background Pulsed-field ablation (PFA) is an innovative non-thermal method for arrhythmia treatment. PFA lesions were assessed by gross pathology, histology, and post-ablation voltage amplitude. The efficacy of various PFA configurations in relation to contact force (CF) has not been well-studied in vivo.

Ablation 40

Ablation Innovation Arrhythmia Article 40

DAIC

DECEMBER 22, 2023

David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians Heart Care and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. David’s Medical Center.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

Dr. S. Venkatesan MD

JUNE 16, 2024

Any deviation or trespassing results in arrhythmia. While , treating VTs with drugs is still a choice, permanent solutions by defining the VT circuit and ablating them, is the new norm. We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us.

Ablation 52

Ablation Physiology Technology Bicuspid/Mitral 52

CineECG

MAY 22, 2023

As ECG Excellence we are proud our CineECG technology was part of this innovation festival. Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patient care. Today we focus on the results of Ramkumar Venkateswaran and Edward Gerstenfeld, both working in UCSF.

Technology 52

Technology Atrial Fibrillation Anatomy Innovation 52

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

MARCH 28, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. 1,ii For patients who had received ablation, median procedure and fluoroscopy times were 90.0 Food & Drug Administration ( FDA ).

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

APRIL 9, 2024

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA).

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

OCTOBER 30, 2024

The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52